发布求助
文献互助 智能选刊 最新文献

Clinical Lymphoma Myeloma and Leukemia最新文献

筛选
英文 中文
POSTER: ABCL-635 An Unusual Case of Extracavitary Primary Effusion Lymphoma 海报:ABCL-635一例罕见的腔外原发性积液性淋巴瘤
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00748-6
F. Jiménez, Claudia García
{"title":"POSTER: ABCL-635 An Unusual Case of Extracavitary Primary Effusion Lymphoma","authors":"F. Jiménez, Claudia García","doi":"10.1016/s2152-2650(23)00748-6","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00748-6","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75510897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: AML-066 Safety and Efficacy of FLAG-IDA-Based Therapy Combined With Venetoclax for the Treatment of Newly Diagnosed and Relapsed/Refractory Patients With AML: A Systematic Review 基于flag - ida的治疗联合Venetoclax治疗新诊断和复发/难治性AML患者的安全性和有效性:一项系统评价
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00410-x
A. Sherban, D. Fredman, S. Shimony, M. Yeshurun, P. Raanani, Maximillian Stahl, A. Gafter-Gvili, O. Wolach
{"title":"POSTER: AML-066 Safety and Efficacy of FLAG-IDA-Based Therapy Combined With Venetoclax for the Treatment of Newly Diagnosed and Relapsed/Refractory Patients With AML: A Systematic Review","authors":"A. Sherban, D. Fredman, S. Shimony, M. Yeshurun, P. Raanani, Maximillian Stahl, A. Gafter-Gvili, O. Wolach","doi":"10.1016/s2152-2650(23)00410-x","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00410-x","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"197 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75934630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: HL-043 Insights into Epidemiological Profile and Diagnosis of Hodgkin Lymphoma 海报:HL-043霍奇金淋巴瘤流行病学概况和诊断的见解
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00674-2
V. Musteata, Valeria Sevcenco, Rodica Mindruta-Stratan
{"title":"POSTER: HL-043 Insights into Epidemiological Profile and Diagnosis of Hodgkin Lymphoma","authors":"V. Musteata, Valeria Sevcenco, Rodica Mindruta-Stratan","doi":"10.1016/s2152-2650(23)00674-2","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00674-2","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"62 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75632284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AML-002 The Effect of Elevated Serum Lactate Dehydrogenase Level on Survival of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients AML-002血清乳酸脱氢酶水平升高对新诊断急性髓性白血病(AML)患者生存的影响
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00975-8
Y. Shaaban, M. Taalab
{"title":"AML-002 The Effect of Elevated Serum Lactate Dehydrogenase Level on Survival of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients","authors":"Y. Shaaban, M. Taalab","doi":"10.1016/s2152-2650(23)00975-8","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00975-8","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73023076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ALL-256 Nelarabine, Etoposide, and Cyclophosphamide for Adult T Cell Acute Lymphoblastic Leukemia/lymphoma Relapsing After Pediatric-Inspired Frontline Approaches: Report of 3 Cases From a Real-Life Setting ALL-256奈拉宾、依托泊苷和环磷酰胺治疗儿科启发的一线治疗后复发的成人T细胞急性淋巴细胞白血病/淋巴瘤:来自现实环境的3例报告
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00941-2
Andrea Pasquini, Gaia Ciolli, F. Mannelli, B. Scappini, G. Gianfaldoni, S. Pilerci, Laura Fasano, E. Quinti, Vivian Paradiso, F. Crupi, R. Starza, A. Vannucchi, M. Piccini
{"title":"ALL-256 Nelarabine, Etoposide, and Cyclophosphamide for Adult T Cell Acute Lymphoblastic Leukemia/lymphoma Relapsing After Pediatric-Inspired Frontline Approaches: Report of 3 Cases From a Real-Life Setting","authors":"Andrea Pasquini, Gaia Ciolli, F. Mannelli, B. Scappini, G. Gianfaldoni, S. Pilerci, Laura Fasano, E. Quinti, Vivian Paradiso, F. Crupi, R. Starza, A. Vannucchi, M. Piccini","doi":"10.1016/s2152-2650(23)00941-2","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00941-2","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"78 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73035533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: ALL-351 Inotuzumab Ozogamicin in the Treatment of Relapsed/Refractory (R/R) Ph-Positive Acute Lymphoid Leukemia (ALL) With Extramedullary Disease: Our Experience 海报:ALL-351 Inotuzumab Ozogamicin治疗复发/难治性(R/R) ph阳性急性淋巴性白血病(ALL)伴髓外疾病:我们的经验
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00399-3
M. Dragoescu, A. Ghiaur, D. Coriu
{"title":"POSTER: ALL-351 Inotuzumab Ozogamicin in the Treatment of Relapsed/Refractory (R/R) Ph-Positive Acute Lymphoid Leukemia (ALL) With Extramedullary Disease: Our Experience","authors":"M. Dragoescu, A. Ghiaur, D. Coriu","doi":"10.1016/s2152-2650(23)00399-3","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00399-3","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73199196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: CT-166 Long-Term Safety With ≥12 Months of Pirtobrutinib in Relapsed/Refractory B-Cell Malignancies 海报:CT-166治疗复发/难治性b细胞恶性肿瘤≥12个月的长期安全性
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00883-2
C. Muehlenbein, Catherine C Coombs, N. Shah, W. Jurczak, J. Woyach, C. Cheah, K. Patel, K. Maddocks, Yucai Wang, Chunxiao Wang, S. Abhyankar, D. E. Tsai, T. Eyre
{"title":"POSTER: CT-166 Long-Term Safety With ≥12 Months of Pirtobrutinib in Relapsed/Refractory B-Cell Malignancies","authors":"C. Muehlenbein, Catherine C Coombs, N. Shah, W. Jurczak, J. Woyach, C. Cheah, K. Patel, K. Maddocks, Yucai Wang, Chunxiao Wang, S. Abhyankar, D. E. Tsai, T. Eyre","doi":"10.1016/s2152-2650(23)00883-2","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00883-2","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74263170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: AML-316 Clinical Outcomes of Adults With Core Binding Factor Acute Myeloid Leukemia (CBF-AML): A Single Center Experience 海报:AML-316成人核心结合因子急性髓性白血病(CBF-AML)的临床结果:单中心经验
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00441-x
Kok Hoe Chan, B. Yohannan, A. Sridhar, A. Rios
{"title":"POSTER: AML-316 Clinical Outcomes of Adults With Core Binding Factor Acute Myeloid Leukemia (CBF-AML): A Single Center Experience","authors":"Kok Hoe Chan, B. Yohannan, A. Sridhar, A. Rios","doi":"10.1016/s2152-2650(23)00441-x","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00441-x","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74316981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: MM-610 Impact of Induction Therapy on the Mobilization and Engraftment of Peripheral Blood Hematopoietic Progenitors for Autologous Transplantation in Patients With Multiple Myeloma. Experience of the University Hospital of Salamanca (Spain) MM-610诱导治疗对多发性骨髓瘤患者自体移植外周血造血祖细胞动员和植入的影响。萨拉曼卡大学医院(西班牙)的经验
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00846-7
S. Gómez, O. López, Maria Luisa Martin, Ana E. Gómez-Úbeda, Beatriz Oreja, Sara Marcos, María Victoria Martín, N. P. Morón, Verónica González de la Calle, Belén Vidriales Vicente, Borja Puertas, A. Hernández, Almudena Navarro, David Alonso, Elena Alejo, C. Puerta, Pablo García, Evelyn Zapata, Marta Fonseca, Miriam López
{"title":"POSTER: MM-610 Impact of Induction Therapy on the Mobilization and Engraftment of Peripheral Blood Hematopoietic Progenitors for Autologous Transplantation in Patients With Multiple Myeloma. Experience of the University Hospital of Salamanca (Spain)","authors":"S. Gómez, O. López, Maria Luisa Martin, Ana E. Gómez-Úbeda, Beatriz Oreja, Sara Marcos, María Victoria Martín, N. P. Morón, Verónica González de la Calle, Belén Vidriales Vicente, Borja Puertas, A. Hernández, Almudena Navarro, David Alonso, Elena Alejo, C. Puerta, Pablo García, Evelyn Zapata, Marta Fonseca, Miriam López","doi":"10.1016/s2152-2650(23)00846-7","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00846-7","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74400538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: AML-233 Incidence of Oral Manifestations in Patients With Hematological Malignancy 海报:AML-233血液恶性肿瘤患者口腔表现的发生率
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00427-5
M. Aly, Merit Rafeek Botros, N. Ameen, Mina Wassem Shokr, Mohammed Nahed Attia Mohammed
{"title":"POSTER: AML-233 Incidence of Oral Manifestations in Patients With Hematological Malignancy","authors":"M. Aly, Merit Rafeek Botros, N. Ameen, Mina Wassem Shokr, Mohammed Nahed Attia Mohammed","doi":"10.1016/s2152-2650(23)00427-5","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00427-5","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74567575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信